James Trayer
Industry influence in healthcare harms patients: myth or maxim?
Trayer, James; Rowbotham, Nicola J.; Boyle, Robert J.; Smyth, Alan R.
Authors
Nicola J. Rowbotham
Robert J. Boyle
Alan R. Smyth
Abstract
Healthcare is a major global industry accounting for a significant proportion of government spending. Drug and medical device manufacturers are publicly traded companies with a responsibility to their shareholders to maximise profits by increasing sales. In order to achieve this, industry exerts influence over every part of healthcare including academic research, medical education, clinical guideline development, physician prescribing and through direct interactions with patients. In contrast, healthcare services seek to provide effective, safe and evidence-based treatments. This article examines interactions with industry across these domains and seeks to identify mutually beneficial relationships and potential conflict leading to patient harms. Case studies are used to illustrate these interactions. There is no single solution for improving healthcare’s relationship with industry, although increased transparency has raised awareness of this issue. We briefly discuss some successful interventions that have been tried at national and regulatory level. While industry influence is widespread in healthcare and this has benefits for shareholders, healthcare practitioners have an ethical obligation to prioritise their patients’ best interests. Industry interactions with healthcare professionals have a valid role in product development and distribution, but industry sponsorship of healthcare education and practice, guideline development or regulatory decision-making can have harmful consequences for patients. Healthcare practitioners need to carefully consider these issues when deciding whether to collaborate with industry.
Citation
Trayer, J., Rowbotham, N. J., Boyle, R. J., & Smyth, A. R. (2022). Industry influence in healthcare harms patients: myth or maxim?. Breathe, 18(2), Article 220010. https://doi.org/10.1183/20734735.0010-2022
Journal Article Type | Review |
---|---|
Acceptance Date | May 31, 2022 |
Online Publication Date | Jul 11, 2022 |
Publication Date | Jun 1, 2022 |
Deposit Date | Jul 15, 2022 |
Publicly Available Date | Jul 19, 2022 |
Journal | Breathe |
Print ISSN | 1810-6838 |
Electronic ISSN | 2073-4735 |
Publisher | European Respiratory Society |
Peer Reviewed | Peer Reviewed |
Volume | 18 |
Issue | 2 |
Article Number | 220010 |
DOI | https://doi.org/10.1183/20734735.0010-2022 |
Keywords | Pulmonary and Respiratory Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/8955359 |
Publisher URL | https://breathe.ersjournals.com/content/18/2/220010 |
Files
Industry influence in healthcare harms patients: myth or maxim?
(500 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
Infection prevention and control in cystic fibrosis: a systematic review of interventions
(2019)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search